Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Daiichi Sankyo Company Limited has reached a basic agreement with Alfresa Pharma Corporation for the transfer of Daiichi's plant in Akita, Japan, to Alfresa Pharma. The move is part of a previously announced plan by Daiichi Sankyo to reorganize...

Sanofi and Immune Design, a clinical-stage immunotherapy company, have formed a licensing agreement for the use of Immune Design's GLAAS discovery platform to develop therapeutic agents to treat a selected food allergy. Immune...

Baxter International Inc. has opened its advanced recombinant biologic facility in Singapore and has announced expansion plans for a new recombinant protein processing suite. The current suite supports the processing of Advate [antihemophilic...

The US Food and Drug Administration (FDA) has approved The Medicines Company's Orbactiv (oritavancin) for injection for the treatment of adults with acute bacterial skin and skin structure infections (ABSSSIs) caused by susceptible designated...

Alvogen, a privately held pharmaceutical company developing, manufacturing and distributing generic, over-the-counter (OTC) brands and biosimilar products, has acquired Dream Pharma, a Seoul, South Korea-based pharmaceutical company offering...

Synta Pharmaceuticals Corp. has named Anne Whitaker as president, chief executive officer and a member of the company's board of directors, effective September 2, 2014. She has more than 20 years of experience in the pharmaceutical...

Allergan, Inc. reported on August 1 that it had filed a lawsuit in the United States District Court for the Central District of California against Valeant Pharmaceuticals International, Inc., Pershing Square Capital Management,...

The specialty pharmaceutical company Impax Laboratories, Inc. announced that the US Food and Drug Administrationperformed a re-inspection of the company's Hayward, California manufacturing facility from June 16 to July 31, 2014. At the conclusion...

Roche has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark. Santaris Pharma's key technology is its proprietary Locked Nucleic Acid (LNA) platform that has contributed to an emerging...

Medivir, a Stockholm-based pharmaceutical company, has entered into a license agreement with Boehringer Ingelheim International GmbH for exclusive, global rights to a drug program for the treatment and prevention of respiratory syncytial virus...

AbbVie reports that the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have granted orphan drug designation to AbbVie's investigational compound ABT-414, an anti-epidermal growth factor receptor antibody...